Alger Focus Equity Z
$118.99-$1.59 (-1.32%)
Alger Focus Equity Z’s quoted price sits in the upper half of its reported 52-week range, 8.34% below the high.
NYSE · GHY · USD
Stock price, dividends, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
PGIM Global High Yield Fund, Inc.’s quoted price sits in the lower half of its reported 52-week range, 15.9% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
PGIM Global High Yield Fund, Inc.’s forward annual dividend is $1.26 per share, paid monthly. The forward yield is 11.56% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow PGIM Global High Yield Fund, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
PGIM Global Short Duration High Yield Fund, Inc. is a closed ended fixed income mutual fund launched and managed by PGIM Investments LLC. The fund is co-managed by PGIM Fixed Income. It invests in fixed income markets across the globe. The fund primarily invests in high yield fixed income instruments of varying maturities that are rated Ba1 or lower by Moody's Investors Service, Inc. or BB+ or lower by Standard & Poor's Ratings Services. It seeks to maintain a weighted average maturity of five years or less. PGIM Global Short Duration High Yield Fund, Inc. was formed on December 26, 2012 and is domiciled in the United States.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:17 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$118.99-$1.59 (-1.32%)
Alger Focus Equity Z’s quoted price sits in the upper half of its reported 52-week range, 8.34% below the high.
$8.67+$0.08 (+0.93%)
BlackRock Debt Strategies Fund, Inc.’s quoted price sits in the lower half of its reported 52-week range, 16.63% below the high.
$14.10-$0.13 (-0.91%)
Nuveen Dow 30 Dynamic Overwrite Fund’s quoted price sits in the lower half of its reported 52-week range, 11.04% below the high.
$6.42+$0.08 (+1.26%)
Voya Global Equity Dividend and Premium Opportunity Fund’s quoted price sits in the upper half of its reported 52-week range, 4.75% below the high.
$7.87-$0.04 (-0.51%)
Calamos Global Dynamic Income Fund’s quoted price sits in the lower half of its reported 52-week range, 14.27% below the high.
$11.10+$0.01 (+0.09%)
Blackstone Strategic Credit Fund’s quoted price sits in the lower half of its reported 52-week range, 7.58% below the high.
$30.07+$0.01 (+0.03%)
Eaton Vance Tax-Advantaged Global Dividend Opportunities Fund’s quoted price sits in the upper half of its reported 52-week range, 7.05% below the high.
$14.09+$0.10 (+0.71%)
Guggenheim Active Allocation Fund’s quoted price sits in the lower half of its reported 52-week range, 14.4% below the high.